Ekso Bionics (EKSO) Misses Q4 EPS by 11c

Ekso Bionics (NASDAQ: EKSO) reported Q4 EPS of ($0.22), $0.11 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $4.85 million versus the consensus estimate of $4.8 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities
• ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04